Discover and read the best of Twitter Threads about #PancChat

Most recents (5)

1/ 🌟 Calling #Oncology HCPs 🌟

🆕 #TumorBoardTuesday #Tweetorial #GI22
🧬 HER2 in Gastrointestinal Cancer
👥 @MPishvaian @BenWestphalen

Supported by educational grants from AstraZeneca Pharmaceuticals & Daiichi Sankyo, Inc.

CME ℹ️ bit.ly/3ruGO07

⁉️ Your specialty
2/ 🗒️ Full reference list & glossary 👉 bit.ly/3tBrmC7

🔑 Key #CME & faculty info 👇, full info 👉 bit.ly/3ruGO07

#TumorBoardTuesday #GI22 Image
3/ 🛑 POLL 🛑

🤔 How frequently do you currently employ emerging novel therapies & clinical trial enrollment for your patients ❓
#TumorBoardTuesday #GI22
Read 21 tweets
1/ 🌟 Calling #Oncology HCPs 🌟

🆕 #TumorBoardTuesday #Tweetorial
🚨 🧬 HER2 in Breast Cancer
👥 @MPishvaian & @ErikaHamilton9

Supported by educational grants from AstraZeneca Pharmaceuticals & Daiichi Sankyo, Inc.

CME ℹ️ bit.ly/3ecVOcC

🗣️ What's your specialty ⁉️
2/ 🗒️ Full reference list & glossary 👉 bit.ly/3yMvIGW

🔑 Key #CME & faculty info 👇, full info 👉 bit.ly/3ecVOcC

#TumorBoardTuesday
3/ 🛑 POLL 🛑

🤔 In a Ph3 trial, which agent has demonstrated an ORR of nearly 80% ❓
#TumorBoardTuesday
Read 24 tweets
1/12 #TumorBoardTuesday
Thurs 10/12/21 Case🎀
@ShaalanBeg @CancerCommons present a case of #PancreaticCancer that challenges us to🤔about cell signaling & mol bio➡️better outcomes.

📚We captured as much of the chat as we could:
twitter.com/i/events/14479…
#PanCan #KRAS #OncTwitter
2/12 #TumorBoardTuesday
Thurs Case🎀

Take🏠messages:
We discussed #PancreaticCancer & specific #KRAS mut
✅All KRAS muts aren’t ≠
✅KRAS G12R➡️⬆️autophagy
✅Autophagy= tumor can♻️cell components ➡️resistance
✅MEKi + autophagy inhib= strat for G12R
✅Repeat NGS on prog is🗝️!
3/12
#TumorBoardTuesday
Thursday Case🎀

👉👉 Don’t forget to pick up 🆓 #CME credit by answering 3 quick ❓
Here is the post-test 🔗: bit.ly/3Bzgply

ALL CME 🔗: integrityce.com/tbt
Read 15 tweets
#PancChat #TumorBoardTuesday

💥A truly unique TBT w/ a hybrid🗣️on BRCA-mut Panc Ca with @letswinpc @drallysonocean & @TumorBoardTues

➡️Here is this week's Thursday Case🎀

👉👉And pick up your🆓#CME credit by answering 2 quick❓

Here is the post-test🔗
surveymonkey.com/r/GBYGYB2
#PancChat #TumorBoardTuesday
Thursday Case🎀
(Case from 04/20/21)

We🗣️a lot about #PancreaticCancer including:
✅Delays to Dx
✅Choosing NOT to have chemo
✅Universal🧬testing
✅BRCA mut & PARP inh

We captured as much as we could in these two moments:
twitter.com/i/events/13838…
#PancChat #TumorBoardTuesday
Thursday Case🎀
(Case from 04/20/21)

And this moment too:
twitter.com/i/events/13838…
Read 19 tweets
#TumorBoardTuesday

🙏for joining &⚖️in on a robust🗣️ with A LOT of deep🔬on NRG-1 fusion+ #CRC led by @benweinbergmd

➡️Here is this week's Thursday Case🎀

👉👉Don't forget to pick up your🆓#CME credit by answering 2 quick❓

Here is the post-test🔗
bit.ly/3fFpTUe
#TumorBoardTuesday
Thursday Case🎀
(Case from 04/06/21)

We discussed #colorectalcancer and:
✅ChemoTx choices and sequencing
✅5FU cardiotox
✅KRAS and other🧬alterations
✅And of course all about NRG-1

We captured as much as we could in this moment:
twitter.com/i/events/13794…
#TumorBoardTuesday
Thursday Case🎀
(Case from 04/06/21)

@benweinbergmd presented a case of a patient with met #CRC

👍2-dary🗣️on:
➡️What chemo after metastasectomy
➡️💪evidence for FOLFOXIRI+mAb for metCRC

ncbi.nlm.nih.gov/pubmed/17470860
ncbi.nlm.nih.gov/pubmed/16508637
ncbi.nlm.nih.gov/pubmed/26338525
Read 13 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!